1,472
Views
29
CrossRef citations to date
0
Altmetric
Review

Alterations in drug disposition in older adults: a focus on geriatric syndromes

, , , &
Pages 41-52 | Received 02 Aug 2020, Accepted 16 Oct 2020, Published online: 02 Nov 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ling Yang, Qi Shen, Chao Hu, Ying Wang, Xiaohong Zhu, Shiqing Shu & Zhu Luo. (2022) Comparative Pharmacokinetics and Safety of Imrecoxib, a Novel Selective Cyclooxygenase-2 Inhibitor, in Elderly Healthy Subjects. Drug Design, Development and Therapy 16, pages 3865-3876.
Read now
Sirasa Ruangritchankul, Prawat Chantharit, Sahaphume Srisuma & Leonard C Gray. (2021) Adverse Drug Reactions of Acetylcholinesterase Inhibitors in Older People Living with Dementia: A Comprehensive Literature Review. Therapeutics and Clinical Risk Management 17, pages 927-949.
Read now

Articles from other publishers (27)

Riccardo Calvani, Anna Picca, Hélio José Coelho-Júnior, Matteo Tosato, Emanuele Marzetti & Francesco Landi. (2023) Diet for the prevention and management of sarcopenia. Metabolism 146, pages 155637.
Crossref
Tomoki Tanaka, Masahiro Akishita, Taro Kojima, Bo-Kyung Son & Katsuya Iijima. (2023) Polypharmacy with potentially inappropriate medications as a risk factor of new onset sarcopenia among community-dwelling Japanese older adults: a 9-year Kashiwa cohort study. BMC Geriatrics 23:1.
Crossref
Xingzhi Guo, Peng Tang, Lina Zhang & Rui Li. (2023) Tobacco and alcohol consumption and the risk of frailty and falling: a Mendelian randomisation study. Journal of Epidemiology and Community Health 77:6, pages 349-354.
Crossref
Ana M Ortega-Villa, Noreen A Hynes, Corri B Levine, Katherine Yang, Zanthia Wiley, Nikolaus Jilg, Jing Wang, Jennifer A Whitaker, Christopher J Colombo, Seema U Nayak, Hannah Jang Kim, Nicole M Iovine, Dilek Ince, Stuart H Cohen, Adam J Langer, Jonathan M Wortham, Robert L Atmar, Hana M El Sahly, Mamta K Jain, Aneesh K Mehta, Cameron R Wolfe, Carlos A Gomez, Tatiana Beresnev, Richard A Mularski, Catharine I Paules, Andre C Kalil, Angela R Branche, Annie Luetkemeyer, Barry S Zingman, Jocelyn Voell, Michael Whitaker, Michelle S Harkins, Richard T DaveyJrJr, Robert Grossberg, Sarah L George, Victor Tapson, William R Short, Varduhi Ghazaryan, Constance A Benson, Lori E Dodd, Daniel A Sweeney & Kay M Tomashek. (2023) Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case. Open Forum Infectious Diseases 10:6.
Crossref
Konstantinos Prokopidis, Panagiotis Giannos, Jean Yves Reginster, Olivier Bruyere, Mirko Petrovic, Antonio Cherubini, Konstantinos K. Triantafyllidis, Konstantinos S. Kechagias, Yannis Dionyssiotis, Matteo Cesari, Kinda Ibrahim, David Scott, Mario Barbagallo & Nicola Veronese. (2023) Sarcopenia is associated with a greater risk of polypharmacy and number of medications: a systematic review and meta‐analysis. Journal of Cachexia, Sarcopenia and Muscle 14:2, pages 671-683.
Crossref
Alexandre González-Rodríguez, Mary V. Seeman, Eloïsa Román, Mentxu Natividad, Carmen Pagés, Camila Ghigliazza, Laura Ros & José A. Monreal. (2023) Critical Issues in the Management of Agitation, Aggression, and End-of-Life in Delusional Disorder: A Mini-Review. Healthcare 11:4, pages 458.
Crossref
Annette Eidam, Julian Marji, Petra Benzinger, Kathrin I. Foerster, Jürgen Burhenne, David Czock, Felicitas Stoll, Antje Blank, Gerd Mikus, Walter E. Haefeli & Jürgen M. Bauer. (2023) Frailty as a Marker for the Plasma Concentrations of Direct Oral Anticoagulants in Older Patients: Results of an Exploratory Study. Drugs & Aging 40:2, pages 153-164.
Crossref
Emily Reeve, Lynn Chenoweth, Mouna Sawan, Tuan Anh Nguyen, Lisa Kalisch Ellett, Julia Gilmartin-Thomas, Edwin Tan, Janet K. Sluggett, Lyntara S. Quirke, Kham Tran, Nagham Ailabouni, Katherine Cowan, Ron Sinclair, Lenore de la Perrelle, Judy Deimel, Josephine To, Stephanie Daly, Craig Whitehead & Sarah N. Hilmer. (2023) Consumer and Healthcare Professional Led Priority Setting for Quality Use of Medicines in People with Dementia: Gathering Unanswered Research Questions. Journal of Alzheimer's Disease 91:3, pages 933-960.
Crossref
Emily Reeve, Elizabeth A Bayliss, Susan Shetterly, Mahesh Maiyani, Kathy S Gleason, Jonathan D Norton, Orla C Sheehan, Ariel R Green, Matthew L Maciejewski, Melanie Drace, Jennifer Sawyer & Cynthia M Boyd. (2023) Willingness of older people living with dementia and mild cognitive impairment and their caregivers to have medications deprescribed. Age and Ageing 52:1.
Crossref
Donal Fitzpatrick & Paul F. Gallagher. 2023. Optimizing Pharmacotherapy in Older Patients. Optimizing Pharmacotherapy in Older Patients 15 31 .
Annette Eidam, Matteo Cesari & Jürgen M. Bauer. 2023. Optimizing Pharmacotherapy in Older Patients. Optimizing Pharmacotherapy in Older Patients 143 159 .
Arduino A. Mangoni & Elzbieta A. Jarmuzewska. 2023. Optimizing Pharmacotherapy in Older Patients. Optimizing Pharmacotherapy in Older Patients 3 14 .
Aalt Bast & Marjolein Drent. (2022) Altered pharmacology and toxicology during ageing: implications for lung disease. Current Opinion in Pulmonary Medicine 28:4, pages 314-320.
Crossref
Juan Tamargo, Keld Per Kjeldsen, Eva Delpón, Anne Grete Semb, Elisabetta Cerbai, Dobromir Dobrev, Gianluigi Savarese, Patrick Sulzgruber, Giuseppe Rosano, Claudio Borghi, Sven Wassmann, Christian Tobias Torp-Pedersen, Stefan Agewall, Heinz Drexel, Iris Baumgartner, Basil Lewis, Claudio Ceconi, Juan Carlos Kaski & Alexander Niessner. (2022) Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. European Heart Journal - Cardiovascular Pharmacotherapy 8:4, pages 406-419.
Crossref
Hossein Omidian, Niloofar Babanejad, Kwadwo Mfoafo, Charise Bertol & Yadollah Omidi. (2022) Toxicity of the polymeric excipients in geriatric polypharmacy. International Journal of Pharmaceutics 622, pages 121901.
Crossref
Vesa Cheng, Mohd H. Abdul-Aziz, Fay Burrows, Hergen Buscher, Amanda Corley, Arne Diehl, Bianca J. Levkovich, Vincent Pellegrino, Claire Reynolds, Sam Rudham, Steven C. Wallis, Susan A. Welch, Jason A. Roberts, Kiran Shekar & John F. Fraser. (2022) Population pharmacokinetics of ciprofloxacin in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study). Anaesthesia Critical Care & Pain Medicine 41:3, pages 101080.
Crossref
Kristie Rebecca Weir, Nagham J Ailabouni, Carl R Schneider, Sarah N Hilmer & Emily Reeve. (2022) Consumer Attitudes Towards Deprescribing: A Systematic Review and Meta-Analysis. The Journals of Gerontology: Series A 77:5, pages 1020-1034.
Crossref
Felicitas Stoll, Annette Eidam, Lola Michael, Jürgen M. Bauer & Walter E. Haefeli. (2022) Drug Treatment of Hypercholesterolemia in Older Adults: Focus on Newer Agents. Drugs & Aging 39:4, pages 251-256.
Crossref
Juliana Junqueira Marques Teixeira, Mercia Pandolfo Provin, Marco Polo Dias Freitas, Fabiana Ribeiro Santana, Marco Tulio Araujo Pedatella & Luis Eduardo de Araujo Rocha. (2022) Impediments to deprescription in Brazil: overview from a panel of geriatrics experts. Geriatrics Gerontology and Aging 16.
Crossref
Anastasia Pana, Panayota Sourtzi, Athina Kalokairinou & Venetia Sofia Velonaki. (2022) Sarcopenia and polypharmacy among older adults: A scoping review of the literature. Archives of Gerontology and Geriatrics 98, pages 104520.
Crossref
Petra Thürmann, Nina-Kristin Mann, Anette Zawinell, Katja Niepraschk-von Dollen & Helmut Schröder. 2022. Arzneimittel-Kompass 2022. Arzneimittel-Kompass 2022 51 76 .
Nagham J. Ailabouni, Gizat M. Kassie & Lisa M. Kalisch Ellett. 2020. Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy. Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy 1 11 .
Arduino A. Mangoni & Elzbieta A. Jarmuzewska. (2021) Incorporating pharmacokinetic data into personalised prescribing for older people: challenges and opportunities. European Geriatric Medicine 12:3, pages 435-442.
Crossref
Kristine M. Erlandson & Damani A. Piggott. (2021) Frailty and HIV: Moving from Characterization to Intervention. Current HIV/AIDS Reports 18:3, pages 157-175.
Crossref
Emily Reeve. (2021) Consideration of frailty versus limited life expectancy when deprescribing. Journal of Pharmacy Practice and Research 51:2, pages 185-186.
Crossref
Arduino A. Mangoni, Kimberley Ruxton & Elzbieta A. Jarmuzewska. 2020. Encyclopedia of Gerontology and Population Aging. Encyclopedia of Gerontology and Population Aging 1 7 .
Arduino A. Mangoni, Kimberley Ruxton & Elzbieta A. Jarmuzewska. 2021. Encyclopedia of Gerontology and Population Aging. Encyclopedia of Gerontology and Population Aging 1524 1530 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.